Geertjan Creemers - b Department of Internal Medicine, Catharina Hospital

N.A.D. Guchelaar, B.J. Noordman, M. Welten, M. van Santen, M.J. de Neijs, S.L. Koolen, R.H.A. Verhoeven,E. Oomen-de Hoop,H.W.M. van Laarhoven,I.H.J.T. de Hingh,G-J. Creemers, B. Mostert,

Annals of Oncology (2023): S884-S884

引用0浏览0引用

70P Fluoropyrimidine (FP) dose individualization based on pretreatment uracil levels: Safety and pharmacokinetic (PK) analysis from the Alpe2U study

M. De With, J. Knikman, A. Baars,G-J.M. Creemers, H.J. Droogendijk, E. Fiets, A.L.T. Imholz, L.B.J. Valkenburg-van Iersel, F.J.F. Jeurissen, C.M.P.W. Mandigers,R.H.N. Van Schaik, B.J.C. van den Bosch,

Annals of Oncology（2022）

引用1浏览0引用

The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: A randomized multi-center study in resectable HER2 overexpressing adenocarcinoma of the esophagus or gastroesophageal junction (TRAP-2)

D. Blange, M. C. C. M. Hulshof,M. I. van Berge Henegouwen, B. Mostert, M. Slingerland,N. Haj Mohammad, M. C. Grootscholten,G-J. M. Creemers, L. J. M. Mekenkamp, E. Fiets, J. J. De Haan, P. Jeene,

Annals of Oncologyno. 7 (2022): S1123-S1124

引用0浏览0引用

412P Phase I study of intraperitoneal irinotecan in combination with standard systemic chemotherapy in patients with extensive peritoneal metastases of colorectal origin: The INTERACT trial

R.A.G. Van Eerden, N.L. De Boer, J.P. van Kooten, C. Bakkers, M.V. Dietz,G-J.M. Creemers, S.M. Buijs, R. Bax, F.M. de Man, R.J. Lurvink, M. Diepeveen, A.R.M. Brandt-Kerkhof,

ANNALS OF ONCOLOGY（2022）

引用0浏览0引用

Gender Differences In Treatment Allocation And Survival In A Real-World Metastatic Pancreatic Cancer Cohort